The Journal of Medical Microbiology, Vol 47, Issue 5 407-416, Copyright © 1998 by Society for General Microbiology

JOURNAL ARTICLE

Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites

A. J. McBain and G. T. Macfarlane
MRC Dunn Clinical Nutrition Centre, Cambridge.

Several hydrolytic and reductive bacterial enzymes (beta-glucuronidase, GN; beta-glucosidase, GS; arylsulphatase, AS; azoreductase, AR; nitroreductase, NR) involved in production of mutagenic or genotoxic metabolites were measured in human colonic contents. Cell-associated AS and extracellular GS were approximately twice as high in the distal colon compared with the proximal bowel, while AR changed little throughout the gut. Measurements of these enzymes in faeces from seven healthy donors confirmed that the majority were cell-associated, and demonstrated high levels of inter-individual variability. NR decreased four-fold between the proximal and distal colon while extracellular GN was reduced by 50%. Most probable number (MPN) analysis on faeces obtained from six healthy donors showed that counts of intestinal bacteria producing GS and AR were c. 10(10) and 10(11)/g, respectively, in all samples tested. Numbers of GN- and AS-forming organisms were between two and three orders of magnitude lower. Inter-individual carriage rates of bacterial populations synthesising NR were highly variable. Screening of 20 pure cultures of intestinal bacteria, belonging to six different genera, showed that Bacteroides ovatus, in particular, synthesised large amounts of GS, whereas B. fragilis, B. vulgatus and Bifidobacterium pseudolongum formed the highest cell-associated levels of GN. In general, bifidobacteria and Lactobacillus acidophilus did not produce significant amounts of AR. All five clostridia studied (Clostridium bifermentans, C. septicum, C. perfringens, C. sporogenes and C. butyricum) produced NR and AR, as did the bacteroides (B. fragilis, B. ovatus and B. vulgatus). Escherichia coli and C. perfringens formed large amounts of NR. Levels of AS production were invariably low and few of the organisms screened synthesised this enzyme. In-vitro studies investigating the effect of intestinal transit time on enzyme production, in a three-stage (V1-V3) continuous culture model of the colon operated at system retention times (R) of either 31.1 or 68.4 h, showed that specific activities of GS were up to four-fold higher (V3) at R = 31.1 h. Bacteriological analysis demonstrated that representative populations of colonic micro-organisms were maintained in the fermentation system, and indicated that changes in GS activity were not related to numbers of the predominant anaerobic or facultative anaerobic species within the model, but were explainable on the basis of substrate-induced modulation of bacterial metabolism.

This article has been cited by other articles:

				C. Humblot, M. Murkovic, L. Rigottier-Gois, M. Bensaada, A. Bouclet, C. Andrieux, J. Anba, and S. Rabot {beta}-Glucuronidase in human intestinal microbiota is necessary for the colonic genotoxicity of the food-borne carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in rats Carcinogenesis, November 1, 2007; 28(11): 2419 - 2425. [Abstract] [Full Text] [PDF]

				M. Blaut and T. Clavel Metabolic Diversity of the Intestinal Microbiota: Implications for Health and Disease J. Nutr., March 1, 2007; 137(3): 751S - 755S. [Abstract] [Full Text] [PDF]

				S. Macfarlane and G. T. Macfarlane Composition and Metabolic Activities of Bacterial Biofilms Colonizing Food Residues in the Human Gut Appl. Envir. Microbiol., September 1, 2006; 72(9): 6204 - 6211. [Abstract] [Full Text] [PDF]

				D. Beaud, P. Tailliez, and J. Anba-Mondoloni Genetic characterization of the {beta}-glucuronidase enzyme from a human intestinal bacterium, Ruminococcus gnavus Microbiology, July 1, 2005; 151(7): 2323 - 2330. [Abstract] [Full Text] [PDF]

				M. M. Huycke and H. R. Gaskins Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models Experimental Biology and Medicine, July 1, 2004; 229(7): 586 - 597. [Abstract] [Full Text] [PDF]

				M. J. Hopkins, H. N. Englyst, S. Macfarlane, E. Furrie, G. T. Macfarlane, and A. J. McBain Degradation of Cross-Linked and Non-Cross-Linked Arabinoxylans by the Intestinal Microbiota in Children Appl. Envir. Microbiol., November 1, 2003; 69(11): 6354 - 6360. [Abstract] [Full Text] [PDF]

				J. Freeman, F. J. O'Neill, and M. H. Wilcox Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gut J. Antimicrob. Chemother., July 1, 2003; 52(1): 96 - 102. [Abstract] [Full Text] [PDF]

				A.J. McBAIN and G.T. MACFARLANE Modulation of genotoxic enzyme activities by non-digestible oligosaccharide metabolism in in-vitro human gut bacterial ecosystems J. Med. Microbiol., September 1, 2001; 50(9): 833 - 842. [Abstract] [Full Text] [PDF]

				W. M. Russell and T. R. Klaenhammer Identification and Cloning of gusA, Encoding a New {beta}-Glucuronidase from Lactobacillus gasseri ADH Appl. Envir. Microbiol., March 1, 2001; 67(3): 1253 - 1261. [Abstract] [Full Text]

				R. SHARP, S. FISHBAIN, and G.T. MACFARLANE Effect of short-chain carbohydrates on human intestinal bifidobacteria and Escherichia coli in vitro J. Med. Microbiol., February 1, 2001; 50(2): 152 - 160. [Abstract] [Full Text] [PDF]